Clinical, prognostic, and therapeutic significance of heat shock protein 27 in bladder cancer

Oncotarget
Myung-Shin LeeJinsung Park

Abstract

Heat shock protein 27 (HSP27) is highly expressed in many cancers, and its prognostic and predictive value has been reported. HSP27 knockdown using siRNA or OGX-427 (an anti-sense oligonucleotide sequence targeting HSP27) is reported to have anti-cancer effects and to enhance chemosensitivity of cancer cells to chemotherapeutic agents. However, conflicting results have been reported regarding the clinical significance of HSP27 in bladder cancer (BC). Furthermore, long-term suppression of HSP27 has not been investigated in BC. In this study, we investigated the association between HSP27 expression and BC characteristics in 132 BC patient samples, as well as its prognostic value to determine the potential of HSP27 as a clinical biomarker. Additionally, we applied five different shRNAs targeting HSP27 in three invasive BC cell lines to analyze the long-term knockdown effects of HSP27. Our study revealed a significant association between HSP27 expression and adverse pathological characteristics such as high-stage and -grade BC. However, HSP27 expression was not associated with clinical outcomes such as tumor recurrence, progression, and patient survival. Interestingly, although our shRNAs had obvious knockdown effects on HSP27 in B...Continue Reading

References

May 11, 1978·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·L MoranA Tissières
Oct 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K H KurthW Oosterlinck
Nov 26, 1999·Breast Cancer Research and Treatment·R K HansenS A Fuqua
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P SteinD G Skinner
Jul 26, 2005·Cell Stress & Chaperones·Daniel R Ciocca, Stuart K Calderwood
Mar 28, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Hyung-Jee KimJi-Young Park
May 14, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Elie HadchityClaire Rodriguez-Lafrasse
Feb 11, 2011·Molecular Medicine·Wun-Jae KimYung Hyun Choi
Apr 8, 2011·Molecular Medicine Reports·Zhijin YuAngao Xu
Nov 28, 2013·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·A TsiaousidouA K Tsaroucha
Jan 31, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Mar 6, 2015·Molecular Cancer Therapeutics·Barbara Lelj-GarollaMartin E Gleave
Sep 15, 2017·Cellular and Molecular Life Sciences : CMLS·Heeyoung SeokSung Wook Chi

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligonucleotides
transfections
transfection
electrophoresis
light microscopy
biopsy

Software Mentioned

InCyte
SE
ImageJ
Stata

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.